Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2735 of 5804
-
Diabetes drug could boost surgery for C-Section scar problems
Disease control Recruiting nowCesarean section scar defect (CSD) is a novel recognized cause of postmenstrual abnormal uterine bleeding in women. No clinical guidelines have been issued for the management of CSD. The investigators have previously demonstrated that vaginal repair of CSD was an relative effecti…
Phase: NA • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a simple vaginal cup help women with fistula leakage?
Symptom relief Recruiting nowThe investigators propose a clinical trial and nested qualitative study to 1) quantify the effectiveness of an insertable vaginal cup to manage fistula urinary incontinence, 2) examine user and implementer acceptability, and 3) quantify fistula management cost. Two intervention m…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Two-in-One training boosts balance and mood in Alzheimer's patients
Symptom relief CompletedThe purpose of this study is to investigate the effects of dual-task training on balance, fear of falling, cognitive functions, dual-task performance, depression and quality of life in individuals with Alzheimer.
Phase: NA • Sponsor: Ege University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New drug aims to lift fatigue and brain fog in liver disease patients
Symptom relief Recruiting nowThe present phase 1b/2 randomised, double-blind, placebo-controlled, two-part study is designed to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of two dose levels of golexanolone compared with placebo among subjects with a history of…
Phase: PHASE1, PHASE2 • Sponsor: Umecrine Cognition AB • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis is a Phase Ib/II study to assess the safety, tolerability and preliminary efficacy of AK119 combined with AK112 in patients with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Brain injection trial hopes to tame Parkinson's
Disease control CompletedSafety and Efficacy Study of BBM-P002 in participants with primary advanced Parkinson's disease
Phase: EARLY_PHASE1 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Smartwatch app aims to tame Kids' meltdowns in real time
Symptom relief CompletedThis community study is a mixed effectiveness-implementation trial of holly™ for delivering information about arousal levels in paediatric populations. This study will evaluate the community implementation of holly™ and gather preliminary data on its impact on quality of life. ho…
Phase: NA • Sponsor: Holland Bloorview Kids Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Can a simple app let families catch hospital errors that staff miss?
Knowledge-focused Recruiting nowHospitals ineffectively examine the safety of their processes by relying on voluntary incident reporting (VIR) by clinical staff who are overworked and afraid to report. VIR captures only 1-10% of events, excludes patients and families, and underdetects events in vulnerable group…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Brain scans seek clues to psychosis in Alzheimer's
Knowledge-focused Recruiting nowThis research project aims to understand the brain mechanisms behind the manifestation of psychotic symptoms in Alzheimer´s disease (AD), and nature of the unique relationship with tau pathology. Amongst the cognitive manifestations of psychosis are impairments related to frontal…
Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New program aims to cut teen pregnancies in At-Risk youth
Prevention OngoingChildren's Hospital Los Angeles and ETR will implement and test the effectiveness of a pregnancy prevention intervention, My Future Self, targeting youth ages 16-19 in Los Angeles and San Diego Counties who, for a variety of reasons, are receiving education or training in non-tra…
Phase: NA • Sponsor: Children's Hospital Los Angeles • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
New psoriasis drug tracked for 5 years in Real-World german study
Disease control OngoingThe purpose of this observational study is to describe the effectiveness of deucravacitinib treatment and quality of life in adults with moderate-to-severe plaque psoriasis in routine clinical practice in Germany over a 5-year period
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New meditation program aims to ease cancer symptoms in black patients
Symptom relief OngoingTo determine the feasibility of implementing a culturally adapted mind-body intervention (Meditation-Based Support-Adapted; MBS-A) as a supportive care strategy in Black patients diagnosed with a stage III-IV solid malignancy. To target the specific needs of Black advanced cancer…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo targets tough cancers in early trial
Disease control Recruiting nowThe goal of this clinical trial is to learn about the safety of NEROFE and doxorubicin and how well it works in patients with advanced/unresectable or metastatic solid KRAS-mutated and ST-positive solid tumors. The main question it aims to answer is to find the recommended dose a…
Phase: PHASE1 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can retraining your brain ease back pain? new study investigates
Symptom relief OngoingThe goal of this clinical trial is to learn which treatment works better for adults with chronic pain. This study is comparing three treatments: Pain Reprocessing Therapy (PRT), Cognitive Behavioral Therapy (CBT), and usual care (whatever a person is already doing to cope with th…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 26, 2026 13:25 UTC
-
Could a zapping cap tame epilepsy seizures?
Disease control Recruiting nowThe purpose of this research is to see to what extent electrical stimulation applied to the scalp (transcranial direct current stimulation or tDCS) can reduce the number and intensity of epileptic seizures.
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
VR therapy shows promise for social isolation in schizophrenia
Symptom relief CompletedVirtual reality (VR) is a novel and innovative intervention method increasingly used in psychiatric research and treatment. VR allows individuals to experience realistic, everyday social situations in a safe and controlled environment. This study aims to examine the effects of a …
Phase: NA • Sponsor: Dokuz Eylul University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Vitamin d shows promise in preventing chronic pain after burns
Prevention CompletedThe goal of this pilot clinical trial is to learn whether vitamin D is able to prevent chronic pain following burn injury and to determine what biological mechanisms are engaged by Vitamin D following burn injury. The main question\[s\] it aims to answer are: * Is the clinical t…
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Cleaner cookstoves may lower blood pressure in nigerian communities
Prevention OngoingUsing a focused implementation research framework, the EPIS (Exploration, Preparation, Implementation and Sustainment) model in a type-2 hybrid design, the study will be conducted in 3 phases: 1) A pre-implementation phase that will use the Exploration and Preparation domains of …
Phase: NA • Sponsor: NYU Langone Health • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
CBD shows promise for traumatic brain injury recovery in small trial
Symptom relief CompletedThis is a double-blind, placebo-controlled, parallel group study designed to assess the tolerability and efficacy of fsCBD and bsCBD, compared to a placebo control, to improve cognition and traumatic brain injury-related symptoms. If eligible for the study, subjects will be rando…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Smart insulin dosing system aims to simplify diabetes management
Disease control OngoingTo evaluate the feasibility of the DexBasal Study System
Phase: PHASE1 • Sponsor: DexCom, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC